Figure 7
(A) The protective effect for in vitro Alzheimer’s disease (AD) cell model (amyloid β-peptide (Aβ)-treated human neuroblastoma-SH-SY5Y cells) by antibody-conjugated PEGylated cerium oxide nanoparticle (CeONP), which was evaluated by the immunofluorescence analysis for heavy neurofilament (NF-H 200) in control, Aβ-treated cells and Aβ–CeONP–Aβ-treated cells.90 Copyright 2012, Elsevier. (B) Comparison of brain infarct volumes in rats treated with various doses of CeONP.91 Copyright 2012, Wiley-VCH. (C) Intravitreal injection of CeONP protects rat retina photoreceptor cells from light-induced degeneration. LE, light exposure; Control, no LE, no injection.96 Copyright 2006, Nature Publishing Group.
